We also examined the proportion of M2b macrophages in CT26 tumor tissues and found that treatment with 8 mg/kg smTRAIL significantly increased M2b macrophage infiltration (high IL-10 and low IL-12 levels) (Fig. 6D). This evidence concerns the gene IL10 and neoplasm.